, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
Registration Statement and Draft Prospectus ______________________________ By virtue of Section 77 of the Securities and Exchange Act, B.E. 2535 (1992), the SEC Office hereby issues the following regulations
virtue of Section 14 and Section 222 in conjunction with Section 206 and Section 207 of the Securities and Exchange Act B.E. 2535 (1992), the Securities and Exchange Commission hereby issues the following
34, Section 36, Section 41, Section 43, and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Securities and Exchange Commission hereby issues the following
Thailand I/We _________________________________________________ as an operator of _____________________________________________ hereby notify the Securities and Exchange Commission, Thailand of our intention
to offer NRI CIS to non-retail investors in Thailand I/We _________________________________________________ as an operator of _____________________________________________ hereby notify the Securities
understanding of the requirements under HK-TH MRF MoU, the SEC hereby would like to clarify the details thereof and provide information on related practices as follows: 1. Objectives of HK-TH MRF MoU HK-TH MRF
related Cooperation (“HK-TH MRF MoU”) on 20 January 2021. To ensure that business operators have the same understanding of the requirements under HK-TH MRF MoU, the SEC hereby would like to clarify the
responsibility towards the incurred damage in all aspects. We hereby acknowledge, understand and agree to abide by the binding agreement above as well as the Agreement on the Registration/Change of Information and
causes damage, we shall assume the responsibility towards the incurred damage in all aspects. We hereby acknowledge, understand and agree to abide by the binding agreement above as well as the Agreement on